Isn't the trial targeted at the Margolis 2 group? Thus making...

Isn't the trial targeted at the Margolis 2 group? Thus making results from this more difficult group even more meaningful. If that is the case and with a placebo, then the result was looking too good, up until week 8 when there was a graph diversion to what would be a more expected result. Of course we won't know till it is all finished. However the company has stated the results are good to date, and if it is so then I for one would appreciate a more comprehensive explanation as to why it believes so. They have said they will keep us informed so why not go the extra yard and explain. If it is as good as suggested then the share price would/should not be wallowing at its current level.
I agree the pain factor is a very considerable aspect.